Oculis Announces Upcoming Presentations on Privosegtor and PIONEER Program

Article summary

Oculis Holding AG announced it will present data on its neuroprotective candidate, Privosegtor, and its ongoing PIONEER clinical program at the upcoming APOIS Congress and CNS Summit.